查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1946650

2026年全球眼科人工智慧輔助診斷市場報告

Ophthalmic Artificial Intelligence-Assisted Diagnosis Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，人工智慧輔助眼科診斷的市場規模迅速擴張，預計將從2025年的21.7億美元成長到2026年的25.7億美元，複合年成長率達18.5%。過去幾年的成長可歸因於數位影像設備的日益普及、眼科疾病率的上升、人們對早期診斷重要性的認知不斷提高、人工智慧在臨床試驗中的應用以及視網膜影像診斷技術的進步。

預計未來幾年，人工智慧輔助眼科診斷市場將快速成長，到2030年市場規模將達到50.3億美元，複合年成長率（CAGR）為18.2%。預測期內的成長要素包括：雲端人工智慧診斷平台的擴展、遠距眼科醫療服務的普及、罕見眼科疾病人工智慧演算法的改進、人工智慧開發商與醫療機構的合作，以及預測性眼科護理的日益普及。預測期內的關鍵趨勢包括：基於人工智慧的視網膜影像分析、基於深度學習的疾病檢測、預測性眼科護理模型、自動化患者病歷分析以及人工智慧在臨床工作流程中的應用。

預計未來幾年，眼科疾病發生率的不斷上升將推動眼科人工智慧輔助診斷市場的擴張。眼科疾病是指影響眼睛結構或功能的疾病或異常情況，可能導致視力障礙或眼睛健康問題。長時間使用電子設備造成的螢幕時間過長，會引發長期的視力問題，例如數位眼疲勞、眼睛乾澀、長時間暴露於藍光以及眨眼頻率降低，從而增加眼科疾病的盛行率。透過分析醫學影像和患者數據，人工智慧輔助眼科診斷能夠準確、早期地檢測、分類和預測眼科疾病，從而促進及時治療，最大限度地降低視力喪失的風險。例如，2023年8月，總部位於瑞士的聯合國機構世界衛生組織（世衛組織）報告稱，全球有超過22億人患有近視或遠視，其中超過10億人的病情是可以預防或未得到治療的。屈光不正和白內障仍然是主要原因，但只有36%的屈光不正患者和17%的白內障患者接受了有效治療。因此，眼科疾病的上升趨勢正在推動人工智慧輔助眼科診斷市場的發展。

眼科人工智慧輔助診斷市場的企業正在加速開發創新解決方案，旨在提高診斷準確性、改善患者照護並提供預測性見解。例如，眼科資料即服務即服務（OSAS）平台就是一個數位化工具，它使眼科醫生、診所和人工智慧診斷系統能夠遠端存取、分析和共用眼科資料（包括視網膜影像），從而提高診斷、監測和監控的品質。例如，2025年5月，拓普康醫療解決方案公司推出了IDHea，這是一個旨在簡化眼科診斷流程並改善眼科疾病管治的同時，促進個人化和主動式患者照護。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球人工智慧輔助眼科診斷市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 人工智慧（AI）和自主人工智慧
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 物聯網、智慧基礎設施和互聯生態系統
    • 工業4.0和智慧製造
  • 主要趨勢
    • 基於人工智慧的視網膜影像分析
    • 利用深度學習進行疾病檢測
    • 預測性眼科學模型
    • 自動化病患記錄分析
    • 將人工智慧融入臨床工作流程

第5章 終端用戶產業市場分析

  • 醫院
  • 診所
  • 診斷影像中心
  • 遠端醫療服務提供者
  • 研究所

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球眼科人工智慧輔助診斷市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球人工智慧輔助眼科診斷市場規模、對比及成長率分析
  • 全球人工智慧輔助眼科診斷市場表現：規模與成長，2020-2025年
  • 全球人工智慧輔助眼科診斷市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按類型
  • 基於雲端的，本地部署的
  • 透過技術
  • 深度學習、機器學習、電腦視覺及其他技術
  • 透過使用
  • 醫院、診所和診斷影像中心
  • 按類型細分：雲端
  • 公共雲端、私有雲端、混合雲端
  • 按類型細分：本地部署
  • 本機伺服器安裝、企業資料中心安裝、專用網路安裝

第10章 區域與國家分析

  • 全球人工智慧輔助眼科診斷市場：按地區、績效和預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球人工智慧輔助眼科診斷市場：國家、市場表現及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 人工智慧輔助眼科診斷市場：競爭格局及市場佔有率（2024年）
  • 人工智慧輔助眼科診斷市場：公司評估矩陣
  • 人工智慧輔助眼科診斷市場：公司概況
    • IDx Technologies Inc.
    • Digital Diagnostics Inc.
    • AEYE Health Inc.
    • Eyenuk Inc.
    • OphtAI

第37章：其他領先和創新企業

  • Oivi Tech Private Limited, Altris Inc., JuneBrain Inc., Mediwhale Inc., MONA.health BV, Remidio Innovative Solutions Pvt. Ltd., Retinalyze System A/S, Retmarker, RetinaRisk, Ikerian AG, VoxelCloud Inc., Visulytix Ltd., Aiforia Technologies Plc, DeepTek Inc., EyRIS Pte Ltd.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年眼科人工智慧輔助診斷市場：提供新機會的國家
  • 2030年人工智慧輔助眼科診斷市場：蘊藏新機會的細分領域
  • 2030年人工智慧輔助眼科診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MOAIA01_G26Q1

Ophthalmic artificial intelligence-assisted diagnosis refers to the use of AI technologies to analyze eye-related medical data, such as retinal images or patient records, for the detection, diagnosis, or monitoring of eye diseases. It combines algorithms such as machine learning and deep learning with imaging and clinical data to support faster, more accurate, and automated decision-making in ophthalmology.

The primary types of ophthalmic AI-assisted diagnosis systems are cloud-based and on-premises. Cloud-based systems are hosted on remote servers and accessed via the internet. Technologies involved include deep learning, machine learning, natural language processing (NLP), computer vision, and others. These systems are applied in settings such as hospitals, clinics, and imaging centers.

Tariffs have influenced the ophthalmic ai-assisted diagnosis market by increasing the import costs of imaging devices, ai-enabled software, and high-resolution cameras. This has particularly affected hospitals, clinics, and imaging centers in Asia-Pacific and Europe. Segments relying on imported retinal cameras and ai software are most impacted. However, tariffs have encouraged local software development and domestic production of imaging systems, which may improve supply chain resilience and reduce long-term costs.

The ophthalmic artificial intelligence-assisted diagnosis market research report is one of a series of new reports from The Business Research Company that provides ophthalmic artificial intelligence-assisted diagnosis market statistics, including ophthalmic artificial intelligence-assisted diagnosis industry global market size, regional shares, competitors with a ophthalmic artificial intelligence-assisted diagnosis market share, detailed ophthalmic artificial intelligence-assisted diagnosis market segments, market trends and opportunities, and any further data you may need to thrive in the ophthalmic artificial intelligence-assisted diagnosis industry. This ophthalmic artificial intelligence-assisted diagnosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ophthalmic artificial intelligence-assisted diagnosis market size has grown rapidly in recent years. It will grow from $2.17 billion in 2025 to $2.57 billion in 2026 at a compound annual growth rate (CAGR) of 18.5%. The growth in the historic period can be attributed to increasing adoption of digital imaging devices, rising prevalence of eye diseases, awareness of early diagnosis, integration of ai in clinical trials, advancements in retinal imaging technology.

The ophthalmic artificial intelligence-assisted diagnosis market size is expected to see rapid growth in the next few years. It will grow to $5.03 billion in 2030 at a compound annual growth rate (CAGR) of 18.2%. The growth in the forecast period can be attributed to growth of cloud-based ai diagnostic platforms, expansion of tele-ophthalmology services, improved ai algorithms for rare eye disorders, partnerships between ai developers and hospitals, increased adoption of predictive ophthalmology. Major trends in the forecast period include AI-based retinal imaging analysis, deep learning-powered disease detection, predictive ophthalmology models, automated patient record analysis, integration of ai with clinical workflows.

The increasing incidence of eye disorders is anticipated to drive the expansion of the ophthalmic artificial intelligence-assisted diagnosis market in the coming years. Eye disorders are medical conditions or abnormalities that affect the structure or function of the eye, potentially leading to impaired vision or compromised eye health. The prevalence of eye disorders is growing due to prolonged screen time from digital device usage, which can result in digital eye strain, dryness, and long-term vision problems from extended blue light exposure and reduced blinking frequency. Ophthalmic artificial intelligence-assisted diagnosis aids by analyzing medical images and patient data to detect, classify, and predict eye disorders with accuracy and at an early stage, facilitating timely treatment and minimizing the risk of vision loss. For example, in August 2023, the World Health Organization (WHO), a Switzerland-based United Nations agency, reported that over 2.2 billion people globally live with near or distance vision impairment-more than 1 billion of whom have preventable or untreated conditions. Refractive errors and cataracts remain the primary causes, while access to effective interventions reaches only 36% of individuals with refractive error-related impairment and just 17% of those with cataract-related impairment. Consequently, the growing prevalence of eye disorders is fueling the development of the ophthalmic artificial intelligence-assisted diagnosis market.

Companies in the ophthalmic AI-assisted diagnosis market are increasingly developing innovative solutions to improve diagnostic accuracy, enhance patient care, and provide predictive insights. One such solution is the ocular data-as-a-service platform, a digital tool that allows ophthalmologists, clinics, and AI diagnostic systems to remotely access, analyze, and share ocular data such as retinal images. This improves diagnosis, monitoring, and research. For instance, in May 2025, Topcon Healthcare Solutions Inc. introduced IDHea, a cloud-based platform designed to streamline ophthalmic diagnostics and improve patient outcomes. By offering fast and secure access to real-world and clinical ocular datasets, IDHea accelerates AI and digital health innovation. It helps researchers generate AI-driven insights to advance both eye and systemic disease care. Built on principles of fast access, safety, and transparency, IDHea facilitates personalized and proactive patient care while ensuring privacy and governance.

In May 2025, Topcon Healthcare Inc. strengthened its AI-driven ophthalmic diagnostic capabilities by acquiring RetInSight GmbH. This acquisition supports the company's objective of advancing global eye care through intelligent diagnostic solutions. RetInSight GmbH, an Austrian medtech company, specializes in AI-assisted ophthalmic diagnostics. With this acquisition, Topcon Healthcare enhances its ability to deliver high-quality eye care, reduce costs, and improve clinical outcomes through innovations in retinal imaging.

Major companies operating in the ophthalmic artificial intelligence-assisted diagnosis market are IDx Technologies Inc., Digital Diagnostics Inc., AEYE Health Inc., Eyenuk Inc., OphtAI, Oivi Tech Private Limited, Altris Inc., JuneBrain Inc., Mediwhale Inc., MONA.health BV, Remidio Innovative Solutions Pvt. Ltd., Retinalyze System A/S, Retmarker, RetinaRisk, Ikerian AG, VoxelCloud Inc., Visulytix Ltd., Aiforia Technologies Plc, DeepTek Inc., EyRIS Pte Ltd., Neurodynamics Solutions Inc.

North America was the largest region in the ophthalmic artificial intelligence-assisted diagnosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ophthalmic artificial intelligence-assisted diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ophthalmic artificial intelligence-assisted diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The ophthalmic artificial intelligence-assisted diagnosis market includes revenues earned by entities by providing services such as technical support and maintenance, clinical trial support, training and consultation, data management, and annotation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The ophthalmic artificial intelligence-assisted diagnosis market also includes sales of wearable eye-tracking devices, retinal scanners, AI-enabled slit-lamp imaging devices, and portable artificial intelligence ophthalmic diagnostic kits. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses ophthalmic artificial intelligence-assisted diagnosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ophthalmic artificial intelligence-assisted diagnosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ophthalmic artificial intelligence-assisted diagnosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Cloud-Based; On-Premises
  • 2) By Technology: Deep Learning; Machine Learning; Computer Vision; Other Technologies
  • 3) By Application: Hospital; Clinic; Imaging Centre
  • Subsegments:
  • 1) By Cloud-Based: Public Cloud; Private Cloud; Hybrid Cloud
  • 2) By On-Premises: Local Server Deployment; Enterprise Data Center Deployment; Private Network Deployment
  • Companies Mentioned: IDx Technologies Inc.; Digital Diagnostics Inc.; AEYE Health Inc.; Eyenuk Inc.; OphtAI; Oivi Tech Private Limited; Altris Inc.; JuneBrain Inc.; Mediwhale Inc.; MONA.health BV; Remidio Innovative Solutions Pvt. Ltd.; Retinalyze System A/S; Retmarker; RetinaRisk; Ikerian AG; VoxelCloud Inc.; Visulytix Ltd.; Aiforia Technologies Plc; DeepTek Inc.; EyRIS Pte Ltd.; Neurodynamics Solutions Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Ai-Based Retinal Imaging Analysis
    • 4.2.2 Deep Learning-Powered Disease Detection
    • 4.2.3 Predictive Ophthalmology Models
    • 4.2.4 Automated Patient Record Analysis
    • 4.2.5 Integration Of Ai With Clinical Workflows

5. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinics
  • 5.3 Imaging Centres
  • 5.4 Telemedicine Providers
  • 5.5 Research Institutes

6. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Segmentation

  • 9.1. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cloud-Based, On-Premises
  • 9.2. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Deep Learning, Machine Learning, Computer Vision, Other Technologies
  • 9.3. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospital, Clinic, Imaging Centre
  • 9.4. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Sub-Segmentation Of Cloud-Based, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Public Cloud, Private Cloud, Hybrid Cloud
  • 9.5. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Sub-Segmentation Of On-Premises, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Local Server Deployment, Enterprise Data Center Deployment, Private Network Deployment

10. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Regional And Country Analysis

  • 10.1. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 11.1. Asia-Pacific Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 12.1. China Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 13.1. India Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 14.1. Japan Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 15.1. Australia Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 16.1. Indonesia Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 17.1. South Korea Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 18.1. Taiwan Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 19.1. South East Asia Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 20.1. Western Europe Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 21.1. UK Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 22.1. Germany Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 23.1. France Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 24.1. Italy Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 25.1. Spain Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 26.1. Eastern Europe Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 27.1. Russia Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 28.1. North America Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 29.1. USA Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 30.1. Canada Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 31.1. South America Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 32.1. Brazil Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 33.1. Middle East Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

  • 34.1. Africa Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Ophthalmic Artificial Intelligence-Assisted Diagnosis Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Regulatory and Investment Landscape

36. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Competitive Landscape And Company Profiles

  • 36.1. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Company Profiles
    • 36.3.1. IDx Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Digital Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. AEYE Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Eyenuk Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. OphtAI Overview, Products and Services, Strategy and Financial Analysis

37. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Other Major And Innovative Companies

  • Oivi Tech Private Limited, Altris Inc., JuneBrain Inc., Mediwhale Inc., MONA.health BV, Remidio Innovative Solutions Pvt. Ltd., Retinalyze System A/S, Retmarker, RetinaRisk, Ikerian AG, VoxelCloud Inc., Visulytix Ltd., Aiforia Technologies Plc, DeepTek Inc., EyRIS Pte Ltd.

38. Global Ophthalmic Artificial Intelligence-Assisted Diagnosis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Ophthalmic Artificial Intelligence-Assisted Diagnosis Market

40. Ophthalmic Artificial Intelligence-Assisted Diagnosis Market High Potential Countries, Segments and Strategies

  • 40.1 Ophthalmic Artificial Intelligence-Assisted Diagnosis Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Ophthalmic Artificial Intelligence-Assisted Diagnosis Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Ophthalmic Artificial Intelligence-Assisted Diagnosis Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer